血管の単一受容体が炎症と修復の両方を引き起こす仕組みを解明(How One Receptor Can Help — or Hurt — Your Blood Vessels)

ad

2026-03-10 カリフォルニア大学サンディエゴ校(UCSD)

カリフォルニア大学サンディエゴ校(UC San Diego)の研究チームは、血管の健康において同じ受容体が状況によって保護的にも有害にも働く仕組みを明らかにした。この受容体は血管内皮細胞の炎症や修復反応を調節しており、特定の条件では血管の回復や正常機能の維持を助ける一方、別の条件では炎症を促進して血管障害を引き起こす可能性がある。研究は血管疾患の発症メカニズム理解を深めるもので、動脈硬化などの心血管疾患に対する新たな治療標的の開発につながる可能性が示された。

血管の単一受容体が炎症と修復の両方を引き起こす仕組みを解明(How One Receptor Can Help — or Hurt — Your Blood Vessels)
This diagram illustrates the two different responses triggered by PAR1. PAR1 can trigger inflammation when activated by thrombin (left) or protection when activated by APC (right). GRK5 and β-arrestin2 each play key roles in these processes, but in different ways depending on the activator.

<関連情報>

プロテアーゼ活性化受容体1のシグナル伝達バイアスは、GRK5とβアレスチン2の異なる決定因子によって決定される Signaling bias of the protease-activated receptor-1 is dictated by distinct GRK5 and β-arrestin-2 determinants

Monica L. Gonzalez Ramirez ∙ Lennis B. Orduña-Castillo ∙ Carolyne Bardeleben ∙ … ∙ Cierra A. Birch ∙ Irina Kufareva ∙ JoAnn Trejo
Cell Reports  Published:March 3, 2026
DOI:https://doi.org/10.1016/j.celrep.2026.117041

Highlights

  • AlphaFold 3 modeling explains the basis of PAR1 signaling bias to thrombin and APC
  • GRK5 membrane anchoring differentially regulates thrombin and APC signaling bias
  • PAR1 phosphorylation and β-arrestin binding distinguish thrombin versus APC signaling
  • Unique β-arrestin conformations underlie thrombin versus APC bias signaling

Summary

G protein-coupled receptors (GPCRs) exhibit signaling bias or preferential activation of heterotrimeric G proteins versus GPCR kinase (GRK)-mediated β-arrestin signaling. The protease-activated receptor-1 (PAR1) activates both G protein and β-arrestin in response to thrombin but only β-arrestin in response to activated protein C (APC). Thrombin-activated PAR1-G protein signaling is desensitized by β-arrestin-1, whereas APC-activated PAR1 signaling is propagated by β-arrestin-2. The mechanisms underlying PAR1 biased signaling are not known. Here, using computational modeling combined with cellular and biochemical studies, we reveal the molecular basis of signaling by thrombin- and APC-activated PAR1. Although both thrombin- and APC-induced PAR1 signaling are regulated by the same GRK, GRK5, the two types of signaling are differentially dependent on GRK5 membrane anchoring, PAR1 C-terminal phosphorylation sites, and the binding mode of β-arrestin-2. These differences translate into distinct β-arrestin-2 conformations and define the APC cytoprotective signaling signature, which contrasts with thrombin inflammatory signaling.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました